ClinicalTrials.Veeva

Menu

iPACK for Post-op Pain Following ACL Reconstruction

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status and phase

Completed
Phase 4

Conditions

ACL Injury
Post Operative Pain

Treatments

Drug: Adductor Canal Block (ACB) + iPACK Block
Drug: Adductor Canal Block (ACB) Only

Study type

Interventional

Funder types

Other

Identifiers

NCT05498870
Pro00121103

Details and patient eligibility

About

This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences in postoperative pain during the first 72 hours when comparing the two groups. Secondary outcomes will include opioid utilization during the first 72 hours postoperatively and range of motion including terminal knee extension at postoperative follow-up visits.

Enrollment

82 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 12 years and older
  • Patients who are scheduled to undergo an ACL reconstruction with quadriceps or BTB graft.

Exclusion criteria

  • Any contraindication to receiving regional anesthesia. This may include infection at the site of injection, allergy to local anesthetic, or pre-existing nerve injury.
  • Patients undergoing hamstring graft or allograft for ACL
  • Pre-existing infection at the site of injury
  • Patients on chronic opioid treatments
  • Pre-existing sensory or motor deficit in operative extremity
  • Patients having a revision of previous ACL reconstruction
  • Pregnant and/or lactating women
  • Weighs less than 40kg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

82 participants in 2 patient groups

Adductor Canal Block (ACB) Only
Active Comparator group
Description:
Participants randomized to the ACB only group will receive an adductor canal block alone.
Treatment:
Drug: Adductor Canal Block (ACB) Only
ACB + iPACK
Active Comparator group
Description:
Participants randomized to the ACB + iPACK group will receive both the ACB and iPACK block.
Treatment:
Drug: Adductor Canal Block (ACB) + iPACK Block

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Haley Nitchie, MHA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems